Histocompatibility Laboratory Billing Services

Premier Histocompatibility Laboratory Billing Services

TransLabs delivers comprehensive billing and revenue cycle management services designed exclusively for histocompatibility and HLA laboratories performing solid organ transplant testing, stem cell transplant evaluation, HLA typing, crossmatching, antibody identification, donor-specific antibody monitoring, and post-transplant surveillance.

Years Serving Laboratories
0 +
Claims Processed Annually
0 M+
Client Retention Rate
0 %
Turn Around Time (TAT)
Hours

The TransLabs Histocompatibility Laboratory Advantage

Histocompatibility and HLA laboratory billing demands specialized expertise in multi-tiered typing codes, professional/technical component separation, transplant indication-specific coding, and antibody panel interpretation. TransLabs’ certified HLA specialists manage resolution-level code selection, crossmatch methodology billing, antibody identification coding, and payer-specific prior authorization to maximize reimbursement and eliminate revenue loss.

Our Performance Metrics Demonstrate Excellence:

First-Pass Claim Rate
0 %
Avg. Reduction in Days in A/R
0 %
Avg. Revenue Growth
8 - 9 %
Payers in Network
0 +

Understanding Histocompatibility & HLA Laboratory Billing Challenges

Histocompatibility and HLA laboratory billing manages the revenue cycle for transplant immunology testing including HLA typing, crossmatching, antibody detection, and post-transplant surveillance. HLA labs face complex tiered typing codes, professional/technical component separation, UNOS documentation, solid organ versus stem cell coding variations, and prior authorization requirements for 70-85% of commercial payers. TransLabs specializes in these critical challenges.

TransLabs specializes in these unique Cytogenetics challenges:

Multi-Tiered HLA Typing Complexity

Expert code selection distinguishing low, intermediate, and high-resolution typing.

Professional vs. Technical Component

Sophisticated separation of transplant immunologist interpretation from technical analysis.

Crossmatch Method Optimization

Strategic billing for flow cytometry, CDC, and virtual crossmatching.

Antibody Identification Panel Coding

Complex sequential testing workflows with proper modifier application for Class I and Class II panels.

UNOS Documentation Integration

Systematic coordination of deceased donor HLA typing with allocation requirements.

Transplant Navigation

Expert understanding of code variations for solid organ versus hematopoietic stem cell transplant.

TransLabs Provides Coverage Across All Laboratory Payors

From commercial insurers to Medicare and Medicaid, our specialists have the lab-exclusive billing expertise to get your claims paid across every network, every time.

Anthem Insurance Aetna Insurance Wellcare Health Insurance Kaiser Permanente Health Insurance Cigna Health Insurance Molina Healthcare Insurance Health Net Insurance Medicaid Government Health Insurance United Healthcare Insurance Humana Health Insurance Blue Cross Blue Shield Insurance Centene Corporation Insurance Oscar Health Insurance Tricare Military Health Insurance Medicare Federal Health Insurance Anthem Insurance Aetna Insurance Wellcare Health Insurance Kaiser Permanente Health Insurance Cigna Health Insurance Molina Healthcare Insurance Health Net Insurance Medicaid Government Health Insurance United Healthcare Insurance Humana Health Insurance Blue Cross Blue Shield Insurance Centene Corporation Insurance Oscar Health Insurance Tricare Military Health Insurance Medicare Federal Health Insurance

Complete RCM Services Across All Histocompatibility Disciplines

TransLabs provides expert billing and coding for the full spectrum of HLA and histocompatibility laboratory testing:

  • Flow cytometry crossmatch (FCXM) – T cell
  • Flow cytometry crossmatch (FCXM) – B cell
  • Complement-dependent cytotoxicity (CDC) crossmatch
  • CDC crossmatch with anti-human globulin (AHG)
  • Pronase-enhanced CDC crossmatch
  • Autocontrol crossmatching
  • Virtual crossmatching (in silico)
  • IgG-specific flow cytometry crossmatch
  • Donor-specific crossmatching (living donor)
  • Pre-transplant crossmatch battery
  • Panel reactive antibody (PRA) screening – Class I
  • Panel reactive antibody (PRA) screening – Class II
  • Single antigen bead (SAB) testing – Class I
  • Single antigen bead (SAB) testing – Class II
  • Luminex antibody identification
  • IgG subclass analysis
  • C1q-binding antibody detection
  • C3d-binding antibody detection
  • Antibody titer determination
  • Serum crossmatch compatibility testing
  • Solid phase antibody screening
  • De novo DSA detection
  • Pre-existing DSA monitoring
  • Serial DSA quantification
  • DSA mean fluorescence intensity (MFI) tracking
  • Post-transplant DSA surveillance
  • C1q/C3d complement-fixing DSA
  • IgG subclass DSA characterization
  • DSA epitope specificity analysis
  • High-resolution HLA matching (10/10, 12/12)
  • Haploidentical donor evaluation
  • Unrelated donor registry searching support
  • Cord blood HLA typing
  • HLA mismatch analysis for GVHD risk
  • Killer immunoglobulin-like receptor (KIR) typing
  • KIR ligand incompatibility assessment
  • Minor histocompatibility antigen testing
  • Kidney transplant HLA typing and crossmatching
  • Liver transplant immunologic workup
  • Heart transplant compatibility testing
  • Lung transplant HLA evaluation
  • Pancreas transplant testing
  • Multi-organ transplant assessment
  • Living donor HLA typing
  • Deceased donor HLA typing (UNOS)
  • HLA epitope mismatch load calculation
  • Eplet mismatch analysis
  • PIRCHE-II score calculation
  • Molecular mismatch scoring
  • Epitope-based risk stratification
  • Acceptable mismatch determination
  • Epitope-level antibody prediction
  • Chimerism analysis (donor/recipient)
  • Acute rejection antibody surveillance
  • Chronic antibody-mediated rejection monitoring
  • Protocol biopsy correlation testing
  • De novo DSA development tracking
  • Engraftment monitoring (stem cell)
  • GVHD immunologic assessment
  • Immunosuppression adequacy monitoring
  • Celiac disease (HLA-DQ2/DQ8)
  • Narcolepsy (HLA-DQB1*06:02)
  • Ankylosing spondylitis (HLA-B27)
  • Behçet’s disease (HLA-B51)
  • Abacavir hypersensitivity (HLA-B*57:01)
  • Carbamazepine hypersensitivity (HLA-B*15:02)
  • Allopurinol hypersensitivity (HLA-B*58:01)
  • Type 1 diabetes risk (HLA-DR/DQ)
  • Next-generation sequencing (NGS) HLA typing
  • Full-length HLA gene sequencing
  • Intronic and regulatory region analysis
  • Phase-ambiguity resolution
  • Novel allele identification
  • HLA haplotype determination
  • Population genetics analysis

Specialized Services For Histocompatibility Labs Nationwide:

Proficient Across Multiple LIS & EHRs to Simplify Your

Laboratory Management

Athena Orchard Eclinical Works Novopath Psyche Systems Veradigm Clinisys Athena Orchard Eclinical Works Novopath Veradigm Clinisys

Why Histocompatibility Laboratories Choose TransLabs

HLA-Exclusive Specialization

Expert in multi-tiered typing, professional/technical separation, UNOS requirements, and transplant-specific coding.

Professional Component Expertise

Expert transplant immunologist interpretation billing (26 modifier), HLA haplotype analysis, and crossmatch interpretation.

Prior Authorization Excellence

95% approval rate for high-resolution typing and antibody identification with proactive submission.

Resolution-Level Coding Mastery

Expert understanding of low, intermediate, and high-resolution typing codes preventing coding violations.

UNOS Integration Expertise

Seamless deceased donor HLA typing coordination with UNOS allocation and stat testing protocols.

Proven Histocompatibility Lab Results

98% clean claims, 35% A/R reduction, and $150K-$450K revenue increases within 90 days.

TransLabs' Histocompatibility Laboratory Billing Best Practices

TransLabs optimizes your histocompatibility laboratory revenue cycle through systematic best practices that ensure maximum reimbursement and operational efficiency.

Professional/Technical Component Optimization

Establish interpretation documentation standards, implement systematic 26 modifier application, and maintain HLA matching analysis documentation.

Resolution-Level Code Selection Accuracy

Apply appropriate CPT codes for low, intermediate, and high-resolution typing with documented methodology preventing coding errors.

Proactive Prior Authorization Management

Identify PA requirements at order entry, submit authorizations with clinical justification, and track approval status in real-time.

Crossmatch Methodology Strategic Billing

Apply correct CPT codes by technique (flow cytometry 86825-86826, CDC 86807-86808) and coordinate crossmatch workflows.

Antibody Identification Panel Optimization

Code Class I and Class II panels separately with appropriate modifiers and create justification for SAB testing.

Frequently Ask Question

How do you handle professional versus technical component billing for HLA testing?

We systematically identify services requiring component separation, ensure transplant immunologist documentation meets payer standards, apply 26 modifiers correctly, and coordinate between laboratory and medical director billing. Our HLA clients typically see 25-35% revenue increases through proper professional component capture.

Yes. We understand CPT codes are tiered by resolution: low (81370-81374), intermediate (81375-81377), and high-resolution (81378-81383), validate resolution-level assignment with methodology, and prevent costly coding errors. Our resolution-level expertise typically increases HLA typing revenue by 20-30%.

We understand solid organ testing differs from stem cell transplant, living donor evaluation differs from deceased donor UNOS-mandated testing, and post-transplant DSA monitoring has frequency limitations. We maintain transplant indication-specific protocols and successfully appeal denials with UNOS policy citations.

Yes. We integrate with all major LIS platforms including EPIC Beaker, Sunquest, Cerner, and HLA-specific systems like Fusion and UNOS DonorNet, enabling automated charge capture and seamless professional/technical coordination.

We identify PA needs at order entry, submit authorizations with comprehensive transplant justification, track approval status with real-time alerts, and achieve 95% PA approval rates preventing automatic denials.

Yes. We understand solid organ testing emphasizes antibody detection while stem cell testing focuses on high-resolution matching, managing both transplant types seamlessly, and navigating distinct coverage policies.

Please Fill out the Form

What Our Clients Say?

Linda Hutchinson
Linda Hutchinson
Laboratory Director
Our NGS panel denials dropped from 32% to under 6% within three months. TransLabs' expertise with molecular tier codes, prior authorization management, and LCD compliance has been invaluable. They understand the nuances of genetic testing billing that our previous vendor completely missed.
Peter Wozniak
Peter Wozniak
Pathologist & Laboratory Owner
We've worked with three other billing companies over the years. TransLabs is the only one that truly understands complex surgical pathology coding, immunohistochemistry billing, and the nuances of TC/PC modifiers. Clean claims rate improved to 99%, and our dermatopathology reimbursement increased 27%.
James Patton
James Patton
Cytogenetics Laboratory Manager
Before TransLabs, our FISH and karyotype claims were a constant struggle with denials and underpayments. Their coders actually understand probe configurations, complexity levels, and when to use 88271 versus 88275. Our cytogenetics revenue increased 34% in the first year.